Eton Pharmaceuticals, Inc. (ETON): Price and Financial Metrics
ETON Price/Volume Stats
Current price | $18.93 | 52-week high | $21.48 |
Prev. close | $19.70 | 52-week low | $3.18 |
Day low | $18.82 | Volume | 400,100 |
Day high | $20.19 | Avg. volume | 286,280 |
50-day MA | $14.90 | Dividend yield | N/A |
200-day MA | $11.28 | Market Cap | 507.66M |
ETON Stock Price Chart Interactive Chart >
Eton Pharmaceuticals, Inc. (ETON) Company Bio
Eton Pharmaceuticals Inc. Eton Pharmaceuticals, Inc. is a is a specialty pharmaceutical company, which is focused on developing and commercializing pharmaceutical products. It products include EM-100, ET-103, CT-100, DS-300, DS-200, and DS-100. The Company focuses on product candidates that are liquid in formulation, including injections, oral liquids and ophthalmics. EM-100 is an ophthalmic product with a preservative-free formulation of the active ingredient ketotifen, and is indicated for the treatment of allergic conjunctivitis. ET-103 is an oral liquid formulation of levothyroxine, which is widely used in tablet and capsule form, and is indicated for the treatment of hypothyroidism. CT-100 is our patent-pending synthetic corticotropin therapeutic candidate that mimics the amino acid chain of injectable product H.P. Acthar Gel. DS-300 is a patent-pending injectable product candidate indicated to treat nutritional deficiencies. DS-200 is an injectable product candidate indicated to treat pain management.
ETON Price Returns
1-mo | N/A |
3-mo | 10.51% |
6-mo | 81.50% |
1-year | 422.93% |
3-year | 480.67% |
5-year | 299.37% |
YTD | 42.12% |
2024 | 204.11% |
2023 | 55.32% |
2022 | -34.27% |
2021 | -47.23% |
2020 | 12.92% |
Continue Researching ETON
Want to do more research on Eton Pharmaceuticals Inc's stock and its price? Try the links below:Eton Pharmaceuticals Inc (ETON) Stock Price | Nasdaq
Eton Pharmaceuticals Inc (ETON) Stock Quote, History and News - Yahoo Finance
Eton Pharmaceuticals Inc (ETON) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...